Prospective Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis. In this study we will evaluate the use of a Biodegradable Endoprothesis: Archimede Fast Biodegradable Pancreatic Stent in patients with high risk of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography. The efficacy and the security of the device will be evaluated.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age\>18 years

• Patients at risk of developing a Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis (procedure and/or patient-related risk factors

Locations
Other Locations
France
Institut Paoli Calmettes
RECRUITING
Marseille
Contact Information
Primary
Dominique Genre, MD
drci.up@ipc.unicancer.fr
+33491223778
Backup
Marc Giovannini, MD
giovanninim@ipc.unicancer.fr
Time Frame
Start Date: 2022-01-20
Estimated Completion Date: 2024-12-15
Participants
Target number of participants: 46
Treatments
Experimental: Prophylactic biodegradable pancreatic stent placement
Sponsors
Leads: Institut Paoli-Calmettes

This content was sourced from clinicaltrials.gov

Similar Clinical Trials